Apogee Therapeutics, Inc. APGE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s enterprise value?
- Apogee Therapeutics, Inc. (APGE) reported enterprise value of $5.84B in Q1 2026.
- How has Apogee Therapeutics, Inc.'s enterprise value changed year-over-year?
- Apogee Therapeutics, Inc.'s enterprise value increased by 181.2% year-over-year, from $2.08B to $5.84B.
- What is the long-term trend for Apogee Therapeutics, Inc.'s enterprise value?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s enterprise value has grown at a 102.7% compound annual growth rate (CAGR), from $1.23B to $5.03B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.